MediFund

MediFund (the Medical Endowment Fund) is Singapore's safety net for Singapore Citizens who still face financial difficulty with medical bills after government subsidies, insurance and MediSave have been applied (MOH, accessed Oct 2026). It is a government endowment fund: the Government invests the capital, and the interest income is allocated to MediFund Committees at approved public healthcare institutions, community hospitals and long-term care facilities, which then help needy patients pay their bills. MediFund is the last of the "S+3Ms" described in healthcare financing, after subsidies, medisave and medishield life. Unlike those layers, MediFund is not an entitlement that a patient plans around: it is need-assessed case by case.

Eligibility and assessment

To be considered for MediFund, a patient must be a Singapore Citizen and a subsidised patient, must have received or need treatment at a MediFund-approved institution, and must be having difficulty paying the bill after government subsidies, insurance and MediSave (MOH, accessed Oct 2026). Permanent residents and foreigners are therefore outside MediFund, and a patient who chose private or unsubsidised care does not qualify for that bill.

MOH states that applications are assessed holistically, taking into account the financial, health and social circumstances of the patient and the patient's family. There is no published income cut-off or fixed benefit amount: each approved institution's independent MediFund Committee decides both whether to help and how much, depending on the family's circumstances and the size of the bill (MOH, accessed Oct 2026). Because the family's means are considered, relatives' ability to contribute can affect the outcome. A claim that a particular household "qualifies for MediFund" or will receive a set percentage should therefore be treated as an estimate, not a rule.

MediFund Silver and MediFund Junior

MediFund Silver and MediFund Junior are carved out of MediFund to give more targeted help to needy seniors and needy children respectively (MOH, accessed Oct 2026). The Agency for Integrated Care (AIC), which handles financial assistance for community care, states that a MediFund Silver care recipient must be a Singapore Citizen aged 65 and above, a subsidised patient at a MediFund-approved institution, and unable to pay after subsidies, insurance and MediSave (AIC, accessed Oct 2026). AIC lists public hospitals, national specialty centres and approved Community Care services among the places where MediFund can help, which means MediFund Silver can reach intermediate and long-term care bills as well as acute hospital bills.

The carve-outs are funded as separate capital sums. In a November 2015 release, MOH reported that MediFund's capital stood at S$2.78 billion and MediFund Silver's at S$1.22 billion as at the end of FY2014, and that MediFund Silver and MediFund Junior had been introduced to better target help at the elderly and children from needy families (MOH, Nov 2015). Those figures are historical and should not be quoted as current fund sizes.

How to apply and history

A patient applies by approaching the Medical Social Workers at the MediFund-approved institution where they received or are receiving care; the social workers can also explore other financing options with the patient (MOH, accessed Oct 2026). AIC similarly directs applicants to the medical social worker at the hospital or institution, and says MediFund covers the medical bill if the application is approved (AIC, accessed Oct 2026). In practice MediFund is therefore accessed through the treating institution rather than applied for in advance.

MediFund was introduced in April 1993. MOH's latest located annual outcome release reports that in FY2024 (1 April 2024–31 March 2025), S$165.1 million was provided across nearly 1.1 million successful applications; 99.9% of applications received that year were approved. Average assistance was S$931 per inpatient admission and S$99 per outpatient visit (MOH, 28 Nov 2025). These are annual programme totals and averages, not a promised award for an individual applicant. Earlier MOH figures reported S$159.3 million in assistance in FY2014, up 22.7% from S$129.8 million the year before, with S$52.4 million going to patients aged 65 and above, and 92% of assisted admissions, attendances and bed months receiving full assistance (MOH, Nov 2015); those FY2014 statistics are historical, not current fund size or current approval rate. The design debate is about discretion: supporters argue that committee assessment directs scarce money to genuine need without creating an open-ended entitlement, while critics note that patients cannot know in advance whether they will be helped, which may deter some from seeking care. For long-term care cash support outside a medical bill, see elderfund.